Revenue | ₹0.54Cr |
Net Profits | ₹0.46Cr |
Net Profit Margins | 85.19% |
Biogen Pharmachem Industries Ltd’s revenue jumped 134.78% since last year same period to ₹0.54Cr in the Q3 2025-2026. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated 640% jump in its revenue since last 3-months.
Biogen Pharmachem Industries Ltd’s net profit jumped 248.39% since last year same period to ₹0.46Cr in the Q3 2025-2026. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated 193.88% jump in its net profits since last 3-months.
Biogen Pharmachem Industries Ltd’s net profit margin jumped 163.2% since last year same period to 85.19% in the Q3 2025-2026. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated -82.62% fall in its net profit margins since last 3-months.
The revenue for Biogen Pharmachem Industries Ltd in the Q3 results 2025 was ₹0.54Cr.
The net profit for Biogen Pharmachem Industries Ltd in the Q3 results 2025 was ₹0.46Cr.
The net profit margin for Biogen Pharmachem Industries Ltd in the Q3 results 2025 was 85.19%.
The revenue for Biogen Pharmachem Industries Ltd in the Q3 results 2024 was ₹0.23Cr.
The net profit for Biogen Pharmachem Industries Ltd in the Q3 results 2024 was ₹0.31Cr.
The net profit margin for Biogen Pharmachem Industries Ltd in the Q3 results 2024 was -134.78%.